By Gabriel Paijo 
Groundbreaking research conducted through a multi-institutional collaboration between the University of Surrey, the John Innes Centre, and Quadram Institute Bioscience has identified a significant nutritional paradox that could reshape public health guidelines regarding vitamin supplementation. The study, published in the peer-reviewed journal Nutrition Reviews, suggests that the consumption of vitamin D2 supplements may actively lower the body’s levels of vitamin D3, the more potent and biologically effective form of the nutrient. This discovery is particularly relevant for populations in northern latitudes, such as the United Kingdom, where sunlight-derived vitamin D is scarce for half the year, leading millions to rely on over-the-counter supplements to maintain bone and immune health.
Vitamin D is a fat-soluble pro-hormone essential for several critical bodily functions, most notably the regulation of calcium and phosphate levels, which are vital for the health of bones, teeth, and muscles. While the UK government currently recommends a daily intake of 10 micrograms (µg) for all citizens during the autumn and winter months, the choice between the two primary forms of the vitamin—D2 (ergocalciferol) and D3 (cholecalciferol)—has long been viewed by many consumers as a matter of secondary importance. However, this new meta-analysis indicates that the two forms are far from interchangeable and may, in fact, have an antagonistic relationship within the human metabolic system.
The Scientific Distinction Between Vitamin D2 and Vitamin D3
To understand the implications of the study, it is necessary to distinguish between the two primary forms of the vitamin available on the market. Vitamin D3 is the form naturally synthesized in human skin through exposure to ultraviolet B (UVB) radiation from sunlight. It is also found in animal-sourced foods, such as oily fish, egg yolks, and liver. In contrast, vitamin D2 is primarily derived from plant sources and fungi, such as yeast or mushrooms exposed to UV light.
For decades, both D2 and D3 have been used in food fortification and as supplements. While it has been previously established that vitamin D3 is more effective at raising total serum 25-hydroxyvitamin D [25(OH)D] levels—the standard measure of vitamin D status in the blood—the discovery that D2 might actually deplete D3 levels represents a significant shift in nutritional science. The researchers found that individuals taking vitamin D2 supplements experienced a measurable drop in their circulating vitamin D3 concentrations compared to control groups who took no D2 supplements at all. This suggests that D2 may interfere with the body’s ability to maintain or utilize its natural D3 stores.
Methodology and Findings of the Meta-Analysis
The research team, led by Emily Brown, a PhD Research Fellow at the University of Surrey, utilized a meta-analysis approach to ensure the highest level of statistical power. By synthesizing data from multiple randomized controlled trials (RCTs), the researchers were able to observe trends across diverse populations and experimental settings. The analysis revealed a consistent pattern: vitamin D2 supplementation resulted in a reduction of vitamin D3 levels. In many instances, the D3 levels in the D2-supplemented groups fell significantly lower than those in the placebo control groups.
"Vitamin D supplements are important, especially between October and March, when our bodies cannot make vitamin D from sunlight in the UK," stated Emily Brown. "However, we discovered that vitamin D2 supplements can actually decrease levels of vitamin D3 in the body, which is a previously unknown effect of taking these supplements. This study suggests that subject to personal considerations, vitamin D3 supplements may be more beneficial for most individuals over vitamin D2."
The biological mechanism behind this depletion is still under investigation, but researchers speculate it may involve the competitive nature of the enzymes responsible for metabolizing vitamin D. Both forms of the vitamin require the same hydroxylation process in the liver and kidneys to become biologically active. It is possible that high doses of D2 saturate these pathways or accelerate the catabolism (breakdown) of existing D3, effectively "crowding out" the more efficient form of the nutrient.
Implications for Immune Function and Disease Defense
The study’s findings are compounded by a previous body of work led by Professor Colin Smith at the University of Surrey, which was published in Frontiers in Immunology. That research utilized transcriptomic analysis to study the effects of D2 and D3 on gene expression in the blood. The results showed that vitamin D3 has a unique and profound impact on the immune system that D2 does not share.
Specifically, vitamin D3 was found to stimulate the type I interferon signaling system. Interferons are critical proteins that serve as the body’s first line of defense against viral and bacterial pathogens. They act as "warning shots," signaling nearby cells to heighten their anti-viral defenses and activating immune cells to attack invaders.
"We have shown that vitamin D3, but not vitamin D2, appears to stimulate the type I interferon signalling system in the body," explained Professor Colin Smith. "A healthy vitamin D3 status may help prevent viruses and bacteria from gaining a foothold in the body."
The fact that D2 might lower D3 levels suggests that individuals relying solely on D2—often favored by those on strict vegan diets due to its plant-based origins—might inadvertently be weakening their immune response to seasonal illnesses like influenza or COVID-19, even if their total vitamin D levels appear adequate on standard tests.
Chronology of Vitamin D Public Health Policy in the UK
The understanding of vitamin D has evolved significantly over the last century, moving from a focus on preventing bone deformities to a broader view of systemic health.
- 1920s-1930s: The discovery of vitamin D as a cure for rickets, a bone-softening disease prevalent in industrialized, smog-filled cities.
- Post-WWII: The introduction of mandatory fortification of margarine and optional fortification of cereals to combat deficiency.
- 2016: The Scientific Advisory Committee on Nutrition (SACN) published a landmark report recommending that everyone in the UK over the age of one should aim for an intake of 10µg of vitamin D daily, particularly during winter.
- 2020-2022: The COVID-19 pandemic sparked renewed interest in vitamin D’s role in respiratory health, leading to large-scale government distributions of supplements to vulnerable populations.
- Current Era: The Surrey, John Innes, and Quadram study marks a new chapter where the quality and form of the vitamin are scrutinized as heavily as the quantity.
Supporting Data: The Scale of Deficiency
The importance of this research is underscored by the high prevalence of vitamin D deficiency in the British population. Data from the National Diet and Nutrition Survey (NDNS) indicates that approximately one in six adults in the UK has low blood levels of vitamin D. During the winter months, this figure rises sharply, with some estimates suggesting that up to 30-40% of the population may be clinically deficient.
The reliance on vitamin D2 in the food industry has historically been driven by cost and its suitability for vegan and vegetarian consumers. However, the new data suggests that this reliance may be misplaced. While D2 is better than no vitamin D at all for bone health, its inability to support the interferon system and its tendency to lower D3 levels make it a suboptimal choice for comprehensive health.
Expert Perspectives and Industry Impact
The collaborative nature of the study highlights a cross-disciplinary concern for national health. Professor Cathie Martin, a Group Leader at the John Innes Centre, emphasized the need for innovation in the plant-based food sector. "This meta-analysis highlights the importance of ensuring plant-based vitamin D3 is accessible in the UK," she noted.
Until recently, vitamin D3 was almost exclusively derived from lanolin (sheep’s wool), making it unsuitable for vegans. However, recent technological advances have allowed for the extraction of D3 from lichens—a symbiotic relationship between algae and fungi. Professor Martin’s comments suggest a push for the food industry to pivot toward these plant-based D3 sources for fortification.
Professor Martin Warren, Chief Scientific Officer at the Quadram Institute, echoed these sentiments, framing the research within the context of food security and nutrient density. "Vitamin D deficiency represents a significant public health concern," Warren said. "This collaborative research effort aligns well with the Quadram Institute’s mission to deliver healthier lives through food innovation to enhance the nutrient density of the food we eat. Tackling this with the most effective form of vitamin D supplementation or fortification is of the utmost importance to the health of the nation."
Analysis of Broader Implications
The findings of this study have far-reaching implications for public health policy, the supplement industry, and individual consumer behavior.
First, there is a clear case for updating public health messaging. Current UK guidelines do not explicitly distinguish between D2 and D3 in their daily 10µg recommendation. If D2 is indeed counterproductive to maintaining D3 levels, health authorities may need to issue specific guidance favoring D3, especially for those at high risk of infection.
Second, the pharmaceutical and nutraceutical industries may face a shift in demand. As consumers become more aware of the "D3 advantage," products containing D2 may see a decline in market share unless they are reformulated. This is particularly relevant for the multi-vitamin market, where D2 is often used due to its stability and lower cost.
Finally, the study opens a new frontier in personalized nutrition. While D3 appears superior for the majority, the researchers noted that choices should be "subject to personal considerations." This acknowledges that some individuals may have specific metabolic profiles or ethical commitments that require a more tailored approach.
Conclusion and Future Research
The revelation that vitamin D2 can lower vitamin D3 levels serves as a reminder of the complexity of human biochemistry. As the scientific community continues to unravel the nuances of how micronutrients interact, the "one-size-fits-all" approach to supplementation is increasingly being questioned.
Further research is now a priority. Scientists aim to conduct more targeted clinical trials to determine the exact dosage at which D2 begins to negatively impact D3 levels and to further explore the long-term effects of D2-only supplementation on immune outcomes. For now, the evidence points toward vitamin D3 as the preferred "first-line" choice for those looking to fortify their health against the challenges of the winter season and beyond. By prioritizing the most effective form of this essential nutrient, the UK may be able to significantly improve the resilience and well-being of its population.
